BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12355754)

  • 1. [An animal model of type 1 diabetes (NOD mice)].
    Nagata M
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():25-32. PubMed ID: 12355754
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal models of insulin-dependent diabetes.
    Liu E; Yu L; Moriyama H; Eisenbarth GS
    Methods Mol Med; 2004; 102():195-212. PubMed ID: 15286387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 4. The NOD mouse model of type 1 diabetes: as good as it gets?
    Atkinson MA; Leiter EH
    Nat Med; 1999 Jun; 5(6):601-4. PubMed ID: 10371488
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transgenic mouse model of type 1 diabetes mellitus].
    Hosoda K; Son C; Fujikura J; Iwakura H; Tomita T; Nakao K
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():70-4. PubMed ID: 12355837
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I diabetes mellitus. A chronic autoimmune disease.
    Eisenbarth GS
    N Engl J Med; 1986 May; 314(21):1360-8. PubMed ID: 3517648
    [No Abstract]   [Full Text] [Related]  

  • 8. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NOD mouse (non-obese diabetic mouse)].
    Moriyama H; Nagata M; Yokono K
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():688-94. PubMed ID: 9513497
    [No Abstract]   [Full Text] [Related]  

  • 10. The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations.
    Apostolou I; Von Boehmer H
    J Autoimmun; 2004 Mar; 22(2):111-4. PubMed ID: 14987738
    [No Abstract]   [Full Text] [Related]  

  • 11. Utilization of NOD mice in the study of type 1 diabetes.
    Karounos DG; Goes SE
    Methods Mol Med; 2003; 83():81-90. PubMed ID: 12619718
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type 1 diabetes mellitus and immunopathology].
    Koike T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():399-406. PubMed ID: 12238080
    [No Abstract]   [Full Text] [Related]  

  • 15. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
    Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
    Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice.
    Katz J; Benoist C; Mathis D
    Eur J Immunol; 1993 Dec; 23(12):3358-60. PubMed ID: 8258349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains.
    Abiru N; Yu L; Miao D; Maniatis AK; Liu E; Moriyama H; Eisenbarth GS
    J Autoimmun; 2001 Aug; 17(1):1-6. PubMed ID: 11488632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of insulitis and diabetes in B cell-deficient NOD mice.
    Yang M; Charlton B; Gautam AM
    J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into insulin dependent diabetes mellitus from studies with transgenic mouse models.
    Grewal IS; Flavell RA
    Lab Invest; 1997 Jan; 76(1):3-10. PubMed ID: 9010445
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
    Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
    Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.